Predictive value of serum procollagen-III-peptide for the survival of patients with cirrhosis
- 30 November 1991
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 13 (3) , 298-304
- https://doi.org/10.1016/0168-8278(91)90072-j
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prophylactic Sclerotherapy before the First Episode of Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1988
- Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronanLiver International, 1987
- Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosisHepatology, 1987
- Procollagen III peptide (PIIIP): Can it reflect hepatic fibrosis?Hepatology, 1987
- Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long‐term follow‐up studyLiver International, 1987
- Prognostic Significance of Serum Bile Acids in CirrhosisHepatology, 1986
- Long-Term Follow-Up of Serum N-Terminal Propeptide of Collagen Type III Levels in Patients with Chronic Liver Disease†Hepatology, 1984
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathyDigestive Diseases and Sciences, 1977
- Survival prediction in portacaval shunts: A computerized statistical analysisThe American Journal of Surgery, 1973